65.4 F
New York
Saturday, September 23, 2023



National Brain Tumor Society to Launch Campaigns Elevating the Necessity of Clinical Trials and Biomarker Testing Access, Guiding More Informed Treatment Decisions

Related Articles

Newton, MA, September 13, 2023 –(PR.com)– National Brain Tumor Society (NBTS), a leader in brain tumor patient advocacy, research, information, and support, today announced the launch of two interrelated public health campaigns focused on patient awareness and access to advanced biomarker testing and clinical trials.

“While continued investment and concerted drug development efforts are certainly needed, the precision medicine era has arrived for patients with brain tumors,” said David Arons, president and chief executive officer of NBTS. “With the World Health Organization’s two recent reclassifications of central nervous system tumors in 2016 and 2021, patients with brain tumors need more precise diagnoses. These recent advances in the understanding of the molecular characteristics of tumor types, as well as new drug approvals and encouraging results from recent clinical trials, call for a greater understanding of…

Read more…

Popular Articles